Full Text View
Tabular View
No Study Results Posted
Related Studies
S-Adenosylmethionine Therapy for Non-Alcoholic Steatohepatitis
This study has been completed.
Study NCT00108589   Information provided by Department of Veterans Affairs
First Received: April 15, 2005   Last Updated: January 20, 2009   History of Changes

April 15, 2005
January 20, 2009
January 2004
 
 
 
Complete list of historical versions of study NCT00108589 on ClinicalTrials.gov Archive Site
 
 
 
S-Adenosylmethionine Therapy for Non-Alcoholic Steatohepatitis
S-Adenosylmethionine Therapy for Non-Alcoholic Steatohepatitis

The purpose of this study is to examine the effect of S-adenosylmethionine therapy in those patients with non-alcoholic liver disease in the form of steatohepatitis (NASH). This will be accomplished by development of a database of these patients, all of whom will have biopsy documented NASH. A placebo controlled trial will then examine the effect of S-adenosylmethionine over time on clinical outcome in these patients. It is expected that this agent will slow or halt the progression of this disease.

 
Phase III
Interventional
Treatment, Randomized, Double-Blind, Placebo Control, Single Group Assignment, Efficacy Study
Hepatitis
Drug: S-adenosylmethionine
 
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Completed
 
December 2006
 

Inclusion Criteria:

  • Men with biopsy proven non-alcoholic steatohepatitis from the liver disease clinic or referred from other physicians from the VAMC-Louisville.
Male
18 Years and older
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00108589
 
CLIN-014-03S
Department of Veterans Affairs
 
 
Department of Veterans Affairs
May 2007

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP